Emetine for Dengue: A Hospital Trial
Part of Infections clinical trials.
This trial tests whether a medicine called emetine can help adults hospitalized with dengue. If you have a confirmed dengue infection and symptoms like fever, headache, or body aches, this study may be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old
- Be currently admitted to the hospital
- Have a lab test confirming dengue virus in the last 5 days (preferably 3)
- Have at least two symptoms such as fever, headache, eye pain, muscle aches, rash, bleeding, or low white blood cells, with fever starting within 72 hours
- Be able to give consent and follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the body responds to a mild, lab-made dengue virus in people who have had dengue before. It looks at how the immune system reacts to a second infection, which may help improve future vaccines and treatments.
This trial tests a new experimental drug, EYU688, for adults with dengue fever. It aims to see if the drug is safe and effective. You may qualify if you have early dengue symptoms, have tested positive for dengue, and are otherwise healthy.
This study tests new medicines for people hospitalized with moderate-to-severe dengue fever. Dengue is a mosquito-borne virus that can cause serious complications like severe bleeding, organ damage, or shock. The trial aims to find treatments that help patients recover faster and avoid life-threatening complications.
This trial tests different experimental drugs to treat dengue early. It aims to find which treatment works best and is safe for patients who start within 48 hours of fever.
This study tests a controlled dengue infection in people who already have immunity to some types of dengue. It aims to understand how the immune system responds and to help develop better vaccines. You may qualify if you are a healthy adult aged 18-40 and have evidence of prior dengue exposure to certain virus types.
This trial tests how the dengue virus affects healthy adults who have never been exposed to dengue or similar viruses. You would be given a controlled dose of the virus and closely monitored to help researchers understand the infection and develop better treatments or vaccines.
Hear when a new Dengue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.